ASND vs. AAPL
Compare and contrast key facts about Ascendis Pharma A/S (ASND) and Apple Inc. (AAPL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ASND or AAPL.
Key characteristics
ASND | AAPL | |
---|---|---|
YTD Return | 8.93% | -4.63% |
1Y Return | 45.94% | 11.20% |
3Y Return (Ann) | -0.29% | 13.45% |
5Y Return (Ann) | 2.58% | 29.21% |
Sharpe Ratio | 1.37 | 0.49 |
Daily Std Dev | 36.27% | 20.67% |
Max Drawdown | -61.72% | -81.80% |
Current Drawdown | -24.93% | -7.32% |
Fundamentals
ASND | AAPL | |
---|---|---|
Market Cap | $7.69B | $2.61T |
EPS | -$9.15 | $6.43 |
Revenue (TTM) | $266.72M | $385.71B |
Gross Profit (TTM) | $39.04M | $170.78B |
EBITDA (TTM) | -$448.99M | $130.11B |
Correlation
The correlation between ASND and AAPL is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ASND vs. AAPL - Performance Comparison
In the year-to-date period, ASND achieves a 8.93% return, which is significantly higher than AAPL's -4.63% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ASND vs. AAPL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and Apple Inc. (AAPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ASND vs. AAPL - Dividend Comparison
ASND has not paid dividends to shareholders, while AAPL's dividend yield for the trailing twelve months is around 0.52%.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Ascendis Pharma A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Apple Inc. | 0.52% | 0.49% | 0.70% | 0.49% | 0.61% | 1.04% | 1.79% | 1.45% | 1.93% | 1.93% | 1.67% | 2.10% |
Drawdowns
ASND vs. AAPL - Drawdown Comparison
The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum AAPL drawdown of -81.80%. Use the drawdown chart below to compare losses from any high point for ASND and AAPL. For additional features, visit the drawdowns tool.
Volatility
ASND vs. AAPL - Volatility Comparison
Ascendis Pharma A/S (ASND) and Apple Inc. (AAPL) have volatilities of 9.22% and 9.16%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ASND vs. AAPL - Financials Comparison
This section allows you to compare key financial metrics between Ascendis Pharma A/S and Apple Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities